
|Articles|February 2, 2002
Early data points to Tx for recalcitrant conditions
Handful of agents promising for melanoma, AK, eczema, psoriasis
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement


















